Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Total revenues, net	$ 175,375	$ 126,173	$ 481,629	$ 332,271
Operating expenses:
Cost of product sales	15,304	9,129	36,558	23,043
Selling, general and administrative	132,101	105,207	366,760	305,144
Research and development	66,819	41,550	165,835	129,368
Total operating expenses	214,224	155,886	569,153	457,555
Loss from operations	(38,849)	(29,713)	(87,524)	(125,284)
Interest income	12,899	5,498	30,523	14,377
Loss before provision for income taxes	(25,950)	(24,215)	(57,001)	(110,907)
Income tax expense	(374)	(43)	(790)	(188)
Net loss	$ (26,324)	$ (24,258)	$ (57,791)	$ (111,095)
Net loss per common share:
Basic (in dollars per share)	$ (0.25)	$ (0.25)	$ (0.57)	$ (1.16)
Diluted (in dollars per share)	$ (0.25)	$ (0.25)	$ (0.57)	$ (1.16)
Weighted average number of common shares:
Basic (in shares)	105,768,386	96,143,083	102,135,530	95,745,641
Diluted (in share)	105,768,386	96,143,083	102,135,530	95,745,641
Product sales, net
Total revenues, net	$ 175,159	$ 125,810	$ 481,278	$ 330,669
Grant revenue
Total revenues, net	$ 216	$ 363	$ 351	$ 1,602